Top experts by indication / Oncology
Most active experts in Lymphoma
2026 edition, data as of October 26, 2026
1,080 key opinion leaders in the directory are tagged to Lymphoma. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 660 of the 1,080 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Julie VoseUniversity of Nebraska Medical Center, NE | 31 trials |
| 2 | Ajay GopalUniversity of Washington School of Medicine, WA | 25 trials |
| 3 | Mitchell CairoNew York Medical College, NY | 23 trials |
| 4 | Thomas WitzigMayo Clinic, MN | 20 trials |
| 5 | Nancy BartlettWashington University School of Medicine, MO | 19 trials |
| 6 | Issa KhouriTX | 17 trials |
| 7 | Brad KahlWashington University School of Medicine in St. Louis, MO | 17 trials |
| 8 | Anas YounesNY | 16 trials |
| 9 | David RizzieriNovant Health Cancer Institute, NC | 15 trials |
| 10 | Jeremy AbramsonMassachusetts General Hospital, MA | 15 trials |
| 11 | Alex HerreraCity of Hope, CA | 14 trials |
| 12 | Alison MoskowitzMemorial Sloan Kettering Cancer Center, NY | 14 trials |
| 13 | Steven HorwitzMemorial Sloan Kettering Cancer Center, NY | 13 trials |
| 14 | Francine FossYale School of Medicine, CT | 13 trials |
| 15 | Luhua WangTX | 12 trials |
| 16 | Jason WestinThe University of Texas MD Anderson Cancer Center, TX | 12 trials |
| 17 | Mary HorowitzMedical College of Wisconsin, WI | 12 trials |
| 18 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 12 trials |
| 19 | Veronika BachanovaUniversity of Minnesota Medical School, MN | 12 trials |
| 20 | Wyndham WilsonNational Cancer Institute (NCI), MD | 12 trials |
| 21 | Sandra HorningCA | 11 trials |
| 22 | Carlos RamosTX | 11 trials |
| 23 | Ian FlinnTennessee Oncology, TN | 11 trials |
| 24 | Jennifer WoyachThe Ohio State University, OH | 11 trials |
| 25 | Stephen AnsellMayo Clinic, MN | 10 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 224 of the 1,080 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Thomas WalshCornell University, NY | 105,956 citations |
| 2 | John DipersioWashington University School of Medicine, MO | 98,282 citations |
| 3 | Shaji KumarMayo Clinic, MN | 95,766 citations |
| 4 | Razelle KurzrockMedical College of Wisconsin, WI | 88,610 citations |
| 5 | Leonard SaltzMemorial Sloan Kettering Cancer Center, NY | 86,391 citations |
| 6 | Gilles SallesMemorial Sloan Kettering Cancer Center, NY | 80,377 citations |
| 7 | Richard ChamplinThe University of Texas MD Anderson Cancer Center, TX | 77,241 citations |
| 8 | Daniel WeisdorfUniversity of Minnesota Medical School, MN | 76,789 citations |
| 9 | Howard BurrisSarah Cannon Research Institute, TN | 72,593 citations |
| 10 | Farhad Ravandi-KashaniThe University of Texas MD Anderson Cancer Center, TX | 71,079 citations |
| 11 | Mario SznolUniversity of Miami Miller School of Medicine, FL | 69,239 citations |
| 12 | David ScaddenMassachusetts General Hospital, MA | 68,183 citations |
| 13 | Stephan GruppChildren's Hospital of Philadelphia, PA | 64,125 citations |
| 14 | William WierdaThe University of Texas MD Anderson Cancer Center, TX | 63,208 citations |
| 15 | Thomas WitzigMayo Clinic, MN | 62,686 citations |
| 16 | Francis GilesTX | 60,986 citations |
| 17 | Wyndham WilsonNational Cancer Institute (NCI), MD | 60,661 citations |
| 18 | Julie VoseUniversity of Nebraska Medical Center, NE | 59,133 citations |
| 19 | Malcolm BrennerBaylor College of Medicine, TX | 59,020 citations |
| 20 | John HainsworthSarah Cannon Research Institute, TN | 58,030 citations |
| 21 | Mary HorowitzMedical College of Wisconsin, WI | 57,794 citations |
| 22 | Elias JabbourThe University of Texas MD Anderson Cancer Center, TX | 56,927 citations |
| 23 | Michael CarducciJohns Hopkins University School of Medicine, MD | 56,123 citations |
| 24 | Ian FlinnTennessee Oncology, TN | 55,739 citations |
| 25 | David MaloneyFred Hutchinson Cancer Center, WA | 54,034 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 175 of the 1,080 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | David ScaddenMassachusetts General Hospital, MA | 37 awards |
| 2 | Hans-Peter KiemWA | 31 awards |
| 3 | Lee RatnerMO | 26 awards |
| 4 | Richard AmbinderJohns Hopkins University School of Medicine, MD | 19 awards |
| 5 | John DipersioWashington University School of Medicine, MO | 15 awards |
| 6 | Edmund WallerEmory University, GA | 13 awards |
| 7 | Jeffrey MillerUniversity of Minnesota Medical School, MN | 13 awards |
| 8 | George WildingWI | 12 awards |
| 9 | Malcolm BrennerBaylor College of Medicine, TX | 12 awards |
| 10 | Bonnie KyUniversity of Pennsylvania, PA | 11 awards |
| 11 | Brenda SandmaierFred Hutchinson Cancer Center, WA | 11 awards |
| 12 | Daniel WeisdorfUniversity of Minnesota Medical School, MN | 10 awards |
| 13 | Neil KayMayo Clinic, MN | 10 awards |
| 14 | Richard JonesJohns Hopkins University School of Medicine, MD | 10 awards |
| 15 | Robert NegrinStanford University School of Medicine, CA | 10 awards |
| 16 | Mark RatainIL | 9 awards |
| 17 | Stephan GruppChildren's Hospital of Philadelphia, PA | 9 awards |
| 18 | Helen HeslopBaylor College of Medicine, TX | 9 awards |
| 19 | Mitchell CairoNew York Medical College, NY | 9 awards |
| 20 | Michael CarducciJohns Hopkins University School of Medicine, MD | 9 awards |
| 21 | Eric ChowWA | 8 awards |
| 22 | Mary HorowitzMedical College of Wisconsin, WI | 8 awards |
| 23 | Supriya MohileUniversity of Rochester Medical Center, NY | 8 awards |
| 24 | Charles ErlichmanMN | 7 awards |
| 25 | Carl AllenTX | 7 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 105 of the 1,080 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Farhad Ravandi-KashaniThe University of Texas MD Anderson Cancer Center, TX | 677 contributions |
| 2 | Shaji KumarMayo Clinic, MN | 449 contributions |
| 3 | Gilles SallesMemorial Sloan Kettering Cancer Center, NY | 319 contributions |
| 4 | Patricia LorussoYale School of Medicine, MI | 272 contributions |
| 5 | James GulleyNational Cancer Institute, MD | 255 contributions |
| 6 | Loretta NastoupilCommonSpirit Medical Oncology Mercy, TX | 245 contributions |
| 7 | Ian FlinnTennessee Oncology, TN | 242 contributions |
| 8 | Thomas WitzigMayo Clinic, MN | 240 contributions |
| 9 | Anthony TolcherNEXT Oncology, TX | 229 contributions |
| 10 | Yi LinMayo Clinic, MN | 226 contributions |
| 11 | Stephen SchusterUniversity of Pennsylvania, PA | 224 contributions |
| 12 | Elizabeth ShpallThe University of Texas MD Anderson Cancer Center, TX | 217 contributions |
| 13 | Sairah AhmedThe University of Texas MD Anderson Cancer Center, TX | 216 contributions |
| 14 | Wendy StockUniversity of Chicago, IL | 210 contributions |
| 15 | Brad KahlWashington University School of Medicine in St. Louis, MO | 208 contributions |
| 16 | Leonard SaltzMemorial Sloan Kettering Cancer Center, NY | 202 contributions |
| 17 | Partow KebriaeiThe University of Texas MD Anderson Cancer Center, TX | 202 contributions |
| 18 | Mazyar ShadmanFred Hutchinson Cancer Center, WA | 199 contributions |
| 19 | Jason WestinThe University of Texas MD Anderson Cancer Center, TX | 198 contributions |
| 20 | John HainsworthSarah Cannon Research Institute, TN | 194 contributions |
| 21 | Gary SchillerUniversity of California, Los Angeles, CA | 193 contributions |
| 22 | Sikander AilawadhiMayo Clinic, FL | 185 contributions |
| 23 | Andrew ZelenetzMemorial Sloan Kettering Cancer Center, NY | 179 contributions |
| 24 | Alessandra FerrajoliThe University of Texas MD Anderson Cancer Center, TX | 177 contributions |
| 25 | Komal JhaveriMemorial Sloan Kettering Cancer Center, NY | 177 contributions |
Emerging
42 of the 1,080 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Inhye AhnHarvard University, MA |
| Othman AkhtarMedical College of Wisconsin, WI |
| Frank BalisChildren's Hospital of Philadelphia, PA |
| Tracy BatchelorBrigham and Women's Hospital, MA |
| Rafael BejarUniversity of California, San Diego, CA |
| Meghan BerkenstockJohns Hopkins University School of Medicine, MD |
| Sharon CastellinoEmory University, GA |
| Nicholas ChiorazziNorthwell Health, NY |
| Saurabh DahiyaCA |
| Bruce DezubeXilio Therapeutics, MA |
| Alexandra DreyzinDC |
| Omotayo FasanUniversity of Pennsylvania, NC |
| Antonio FojoColumbia University Irving Medical Center, NY |
| Daphne FriedmanDuke University, NC |
| Nima GhalehsariMoffitt Cancer Center, FL |
| Stanton GoldmanMedical City Children's Hospital, TX |
| Sagun GoyalSaint Louis University Hospital, MO |
| Walter HanelThe Ohio State University, OH |
| Douglas HawkinsSeattle Children's Hospital, WA |
| Herbert HurwitzDuke University, NC |
| Thomas JandlStony Brook University Hospital, NY |
| Enrico LallanaKaiser Permanente, CA |
| Abraham LeungPfizer, CA |
| Wells MessersmithUniversity of Colorado Cancer Center, CO |
| Sara MonaghanTX |
How these tables are computed
The cohort is every profile in the directory tagged to Lymphoma, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Lymphoma profile in the directory